A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study was designed to explore the safety and efficacy of Bevacizumab combined with Fluzoparib, Bevacizumab combined with chemotherapy or Fluzoparib monotherapy in patients with platinum-resistant recurrent ovarian cancer.
Epistemonikos ID: bbffbad1148a8dec526ee2bf54473944a3517c1a
First added on: May 09, 2024